ArticleFrontiers in oncology2026

RPL28 mediates sorafenib resistance in hepatocellular carcinoma by downregulating CDC6 expression.

Yi Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.